This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Biopharma Remove Networking Remove Pharmaceutical products Related Topics
Side effects Pharma Safety Leads Healthcare Patients Transportation Retail Distribution Medicine More Related Topics >
article thumbnail

Pharma’s climate change vulnerability and opportunity

pharmaphorum

SEPTEMBER 9, 2022

In 2019, the pharmaceutical industry produced 48.55 As a critical industry, any disruption to the production or distribution of pharmaceutical products can have significant cost implications for the industry and health ramifications for the global population”. Vulnerability . Making plans is not enough.

Distribution 85
Distribution Pharma Pharmaceutical Pharmaceutical products 85
article thumbnail

Practical advice for Early Scientific Advice (ESA) in HTA submissions

pharmaphorum

SEPTEMBER 28, 2022

In recent years, the biopharma market has become progressively complex. As a result, payers are feeling increased pressure to make the right decisions based on the perceived value of each product. HTA agencies can assist biopharma companies at the early stages of development to ensure they are meeting the expectations of payers.

Biopharma 52
Biopharma Side effects Consulting Pharmaceutical products 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 8,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024